PMID: 7540876Apr 1, 1995Paper

Human papillomavirus infection and genital warts: update on epidemiology and treatment

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
K M Stone

Abstract

The treatment of genital warts remains frustrating since it is often painful, expensive, and unsuccessful. Moreover, little is known about the infectivity and natural history of exophytic genital warts or subclinical genital infection with human papillomavirus. The traditional goals of therapy for sexually transmitted diseases--eradication of infection, elimination of symptoms, prevention of long-term sequelae, and interruption of transmission--are currently not attainable for or applicable to genital warts. The medical literature from January 1988 to August 1993 was reviewed for recent studies on the treatment of exophytic warts. The following treatments were included in the reviewed studies: podofilox (which was recently approved by the Food and Drug Administration), podophyllin, cryotherapy, topical 5-fluorouracil, intralesional interferon, systemic interferon, and laser surgery. No single treatment modality was superior to another, and recurrence rates associated with all modalities were high. Treatment of genital warts should be guided by preferences of the patient, and a specific therapeutic regimen should be chosen with consideration of expense, efficacy, convenience, and potential for adverse effects.

Citations

May 7, 2002·Journal of Medical Virology·Ilse StragierHugo De Greef
Jul 4, 2006·Indian Journal of Pediatrics·Nahed Abdel-HaqBasim Asmar
Dec 3, 2003·Archives of Gynecology and Obstetrics·Dimitrios HaidopoulosStylianos Michalas
May 1, 1997·Journal of Nurse-midwifery·V A Roe, A Gudi
Apr 1, 1997·Dermatologic Clinics·G E Baker, S K Tyring
Dec 1, 1999·Infectious Disease Clinics of North America·L L Patton, C van der Horst
Feb 26, 2010·The International Journal of Clinical and Experimental Hypnosis·Arreed BarabaszMarianne Barabasz
Jun 28, 2003·Viral Immunology·Gretchen L EibenW Martin Kast
Aug 13, 2002·Sexually Transmitted Diseases·Linar R ClarkLynne Allen-Taylor
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E D MoreiraG Karic
Dec 1, 1996·Genitourinary Medicine·I H Frazer
Aug 23, 2001·Infectious Diseases in Obstetrics and Gynecology·S A Gall
Feb 20, 1998·AWHONN Lifelines·P G Higgins, P E Smith
May 16, 2012·Journal of the American Academy of Dermatology·Rachel H Gormley, Carrie L Kovarik
Oct 27, 1999·Journal of the American Academy of Dermatology·T J BrownS K Tyring
Apr 1, 1997·Dermatologic Clinics·L L McDonaldD M Buntin
May 5, 1997·The American Journal of Medicine·K R Beutner, A Ferenczy
May 5, 1997·The American Journal of Medicine·M Reitano
Jul 1, 2000·Journal of Lower Genital Tract Disease·A Ferenczy
Jan 29, 2000·Journal of Clinical Pharmacy and Therapeutics·A Tariq, J D Ross
Aug 5, 2016·Journal of Lower Genital Tract Disease·Laura Alicia FleiderMaría Silvia Perez
Mar 30, 2006·International Journal of Cancer. Journal International Du Cancer·UNKNOWN International Collaboration of Epidemiological Studies of Cervical Cancer
Apr 16, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·R D MawM Nathan
Feb 15, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·C MartinelliI Ruffino
Jan 6, 1999·Antiviral Chemistry & Chemotherapy·K SudoT Yokota
Nov 5, 1998·Journal of the American Academy of Nurse Practitioners·E H Neill, J B Waldrop
May 28, 2010·Journal of Medical Economics·Nadia Demarteau, Baudouin Standaert
Feb 13, 2001·Journal of Cutaneous Pathology·J ArreseG Piérard
Jan 1, 1997·The Physician and Sportsmedicine·J R Clark
Apr 2, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·UNKNOWN International Collaboration of Epidemiological Studies of Cervical Cancer
Apr 29, 1998·Antimicrobial Agents and Chemotherapy·K R BeutnerK A Schmitt
Oct 14, 1998·The Medical Clinics of North America·T Rosen, T J Brown

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
M R SpitzG R Newell
International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
J J Klutke, A Bergman
© 2021 Meta ULC. All rights reserved